Literature DB >> 17675407

Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans.

Takatoshi Hikida1, Hanna Jaaro-Peled, Saurav Seshadri, Kenichi Oishi, Caroline Hookway, Stephanie Kong, Di Wu, Rong Xue, Manuella Andradé, Stephanie Tankou, Susumu Mori, Michela Gallagher, Koko Ishizuka, Mikhail Pletnikov, Satoshi Kida, Akira Sawa.   

Abstract

Here, we report generation and characterization of Disrupted-In-Schizophrenia-1 (DISC1) genetically engineered mice as a potential model for major mental illnesses, such as schizophrenia. DISC1 is a promising genetic risk factor for major mental illnesses. In this transgenic model, a dominant-negative form of DISC1 (DN-DISC1) is expressed under the alphaCaMKII promoter. In vivo MRI of the DN-DISC1 mice detected enlarged lateral ventricles particularly on the left side, suggesting a link to the asymmetrical change in anatomy found in brains of patients with schizophrenia. Furthermore, selective reduction in the immunoreactivity of parvalbumin in the cortex, a marker for an interneuron deficit that may underlie cortical asynchrony, is observed in the DN-DISC1 mice. These results suggest that these transgenic mice may be used as a model for schizophrenia. DN-DISC1 mice also display several behavioral abnormalities, including hyperactivity, disturbance in sensorimotor gating and olfactory-associated behavior, and an anhedonia/depression-like deficit.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17675407      PMCID: PMC1964873          DOI: 10.1073/pnas.0704774104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

Review 1.  MRI anatomy of schizophrenia.

Authors:  R W McCarley; C G Wible; M Frumin; Y Hirayasu; J J Levitt; I A Fischer; M E Shenton
Journal:  Biol Psychiatry       Date:  1999-05-01       Impact factor: 13.382

2.  Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics.

Authors:  C L Beasley; G P Reynolds
Journal:  Schizophr Res       Date:  1997-04-11       Impact factor: 4.939

3.  A motion correction scheme by twin-echo navigation for diffusion-weighted magnetic resonance imaging with multiple RF echo acquisition.

Authors:  S Mori; P C van Zijl
Journal:  Magn Reson Med       Date:  1998-10       Impact factor: 4.668

4.  Inhibition of NUDEL (nuclear distribution element-like)-oligopeptidase activity by disrupted-in-schizophrenia 1.

Authors:  Mirian A F Hayashi; Fernanda C V Portaro; Marta F Bastos; Juliano R Guerreiro; Vitor Oliveira; Silvia S Gorrão; Denise V Tambourgi; Osvaldo A Sant'Anna; Paul J Whiting; L Miguel Camargo; Katsuhiro Konno; Nicholas J Brandon; Antonio C M Camargo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-23       Impact factor: 11.205

Review 5.  The neuropathology of schizophrenia. A critical review of the data and their interpretation.

Authors:  P J Harrison
Journal:  Brain       Date:  1999-04       Impact factor: 13.501

Review 6.  Cortical inhibitory neurons and schizophrenia.

Authors:  David A Lewis; Takanori Hashimoto; David W Volk
Journal:  Nat Rev Neurosci       Date:  2005-04       Impact factor: 34.870

7.  Expression of disrupted in schizophrenia 1 (DISC1) protein in the adult and developing mouse brain indicates its role in neurodevelopment.

Authors:  I L Schurov; E J Handford; N J Brandon; P J Whiting
Journal:  Mol Psychiatry       Date:  2004-12       Impact factor: 15.992

Review 8.  The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis.

Authors:  R E Steinpreis
Journal:  Behav Brain Res       Date:  1996-01       Impact factor: 3.332

9.  Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism.

Authors:  Y Oike; A Hata; T Mamiya; T Kaname; Y Noda; M Suzuki; H Yasue; T Nabeshima; K Araki; K Yamamura
Journal:  Hum Mol Genet       Date:  1999-03       Impact factor: 6.150

10.  Schizophrenia syndromes associated with changes in ventricle-to-brain ratios: a serial high-resolution three-dimensional magnetic resonance imaging study in first-episode schizophrenia patients using subvoxel registration and semiautomated quantification.

Authors:  B K Puri; N Saeed; A J Richardson; A Oatridge; J V Hajnal; G M Bydder
Journal:  Int J Clin Pract       Date:  2005-04       Impact factor: 2.503

View more
  215 in total

Review 1.  Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders.

Authors:  Susan B Powell; Martin Weber; Mark A Geyer
Journal:  Curr Top Behav Neurosci       Date:  2012

Review 2.  Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and development.

Authors:  Christina Wilson; Alvin V Terry
Journal:  Clin Schizophr Relat Psychoses       Date:  2010-07

Review 3.  Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap.

Authors:  Judith Pratt; Catherine Winchester; Neil Dawson; Brian Morris
Journal:  Nat Rev Drug Discov       Date:  2012-06-22       Impact factor: 84.694

Review 4.  Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches.

Authors:  Andrea de Bartolomeis; Gianmarco Latte; Carmine Tomasetti; Felice Iasevoli
Journal:  Mol Neurobiol       Date:  2013-09-03       Impact factor: 5.590

Review 5.  Defects in Bioenergetic Coupling in Schizophrenia.

Authors:  Courtney R Sullivan; Sinead M O'Donovan; Robert E McCullumsmith; Amy Ramsey
Journal:  Biol Psychiatry       Date:  2017-10-24       Impact factor: 13.382

Review 6.  Psychiatric behaviors associated with cytoskeletal defects in radial neuronal migration.

Authors:  Toshifumi Fukuda; Shigeru Yanagi
Journal:  Cell Mol Life Sci       Date:  2017-05-17       Impact factor: 9.261

7.  TAR DNA-Binding Protein 43 and Disrupted in Schizophrenia 1 Coaggregation Disrupts Dendritic Local Translation and Mental Function in Frontotemporal Lobar Degeneration.

Authors:  Ryo Endo; Noriko Takashima; Yoko Nekooki-Machida; Yusuke Komi; Kelvin Kai-Wan Hui; Masaki Takao; Hiroyasu Akatsu; Shigeo Murayama; Akira Sawa; Motomasa Tanaka
Journal:  Biol Psychiatry       Date:  2018-03-29       Impact factor: 13.382

Review 8.  Postmortem brain: an underutilized substrate for studying severe mental illness.

Authors:  Robert E McCullumsmith; John H Hammond; Dan Shan; James H Meador-Woodruff
Journal:  Neuropsychopharmacology       Date:  2013-10-04       Impact factor: 7.853

9.  A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition.

Authors:  Mirna Kvajo; Heather McKellar; P Alexander Arguello; Liam J Drew; Holly Moore; Amy B MacDermott; Maria Karayiorgou; Joseph A Gogos
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-05       Impact factor: 11.205

10.  DISC1 regulates new neuron development in the adult brain via modulation of AKT-mTOR signaling through KIAA1212.

Authors:  Ju Young Kim; Xin Duan; Cindy Y Liu; Mi-Hyeon Jang; Junjie U Guo; Nattapol Pow-anpongkul; Eunchai Kang; Hongjun Song; Guo-li Ming
Journal:  Neuron       Date:  2009-09-24       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.